Tracking survival in advanced liver cancer patients on new immune drugs
Disease control
Not yet recruiting
This study aims to track how well patients with advanced liver cancer do while receiving immune checkpoint inhibitor drugs as part of their regular treatment. Researchers will follow 75 patients to measure how long they live and how long the cancer stays controlled, while also mo…
Sponsor: Ahmed Karam Helmy • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC